Page 48 - Read Online

Page 12 of 12 Politei et al. Rare Dis Orphan Drugs J 2024;3:10 https://dx.doi.org/10.20517/rdodj.2023.46

correlations from the phase 3 FACETS trial. Orphanet J Rare Dis 2018;13:68. DOI PubMed PMC
48. Shayman JA, Hinkovska-galcheva V, Shu L. Inhibitors of glucosylceramide synthase. In: Kabayama K, Inokuchi J, editors.
Glycolipids. New York: Springer; 2023. pp. 271-88. DOI
49. Wanner C, Kimonis V, Politei J, et al. Understanding and modifying Fabry disease: rationale and design of a pivotal phase 3 study and
results from a patient-reported outcome validation study. Mol Genet Metab Rep 2022;31:100862. DOI PubMed PMC
50. Deegan PB, Goker-Alpan O, Geberhiwot T, et al. Venglustat, an orally administered glucosylceramide synthase inhibitor: assessment
over 3 years in adult males with classic Fabry disease in an open-label phase 2 study and its extension study. Mol Genet Metab
2023;138:106963. DOI PubMed PMC
51. Burlina AP, Sims KB, Politei JM, et al. Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of
neuropathic pain: the report of an expert panel. BMC Neurol 2011;11:61. DOI PubMed PMC
52. Ries M, Mengel E, Kutschke G, et al. Use of gabapentin to reduce chronic neuropathic pain in Fabry disease. J Inherit Metab Dis
2003;26:413-4. DOI
53. Gugelmo G, Vitturi N, Francini-Pesenti F, et al. Gastrointestinal manifestations and low-fodmap protocol in a cohort of Fabry disease
adult patients. Nutrients 2023;15:658. DOI PubMed PMC
54. Lenders M, Boutin M, Auray-Blais C, Brand E. Effects of orally delivered alpha-galactosidase A on gastrointestinal symptoms in
patients with Fabry disease. Gastroenterology 2020;159:1602-4. DOI PubMed
55. Monticelli M, Hay Mele B, Allocca M, et al. Curcumin Has beneficial effects on lysosomal alpha-galactosidase: potential implications
for the cure of Fabry disease. Int J Mol Sci 2023;24:1095. DOI PubMed PMC
56. Bertoldi G, Carraro G, Ravarotto V, et al. The effect of green tea as an adjuvant to enzyme replacement therapy on oxidative stress in
fabry disease: a pilot study. Front Nutr 2022;9:924710. DOI PubMed PMC